The Department of Health and Social Care will convene a programme board to implement all 44 recommendations from the National Commission into the Regulation of AI in Healthcare, accepting the doctors-led blueprint that ministers commissioned after more than 12,000 public responses on how machine learning should be deployed in the NHS.
The commission’s report, published on 10 September 2026, urged clearer accountability for algorithmic tools used in diagnostics, scheduling and triage, alongside stronger post-market surveillance when models update from live hospital data. The government’s response on 6 October confirmed acceptance of every line and promised a full implementation roadmap by spring 2027.
Regulatory sandbox expands
Alongside the policy response, the Medicines and Healthcare products Regulatory Agency opened applications for the third phase of AI Airlock, its regulatory sandbox for AI-enabled medical devices. Themes for the cohort draw directly from commission priorities, including real-world monitoring and human oversight when models assist clinicians. A webinar for prospective applicants is scheduled for 22 October, with the first wave of innovators to be selected in November.
MHRA chief executive Dr Laura Squire used the launch to tie the sandbox to the agency’s wider 2030 strategy, published on 14 October, which commits to faster access to safe innovation while keeping patients at the centre of decisions. The strategy mentions women’s health plans, diversity in clinical studies and new methodologies for software that learns after deployment.
What clinicians asked for
Commission hearings highlighted friction points familiar to NHS trusts: procurement teams buying overlapping chatbots, ward staff unsure whether an AI triage score is advisory or binding, and information governance boards struggling to assess vendor claims. Recommendations include national standards for impact assessments, mandatory incident reporting when algorithms contribute to harm, and training pathways so registrars understand model limitations.
Devolved administrations will sit on the programme board alongside NHS England, the MHRA and digital teams. Welsh and Scottish health systems already run separate data trusts; the board’s job is to keep UK-wide principles aligned without blocking local innovation pilots.
Industry and privacy
Health-tech vendors welcomed the sandbox extension but warned that procurement cycles must shorten if the UK wants to retain developers tempted by US and EU markets. Privacy campaigners urged the board to publish decision logs when NHS data is used to fine-tune commercial models, a topic the commission flagged without prescribing a single IT architecture.
For patients, the near-term visible changes may be mundane: clearer consent forms in outpatient letters, labels on apps that explain when a human clinician reviews AI output, and fewer duplicate questionnaires across trusts. Longer term, successful Airlock graduates could speed approvals for tools that read retinal scans or predict sepsis — provided post-market monitoring proves they work for Britain’s diverse population.
Next milestones
Trust chief information officers should expect procurement framework updates this winter, while clinicians can attend the 22 October MHRA briefing if their hospitals are considering sandbox entry. The programme board’s first public progress report is due before the roadmap lands next year — the moment ministers will be judged on whether acceptance on paper becomes safer care in practice.